L & M CHEMICAL (00746) announces its interim performance, with profits increasing by 36.0% to HK$327 million. The interim dividend per share is 19.5 HK cents.
Li & Fung (00746) announced its mid-term performance for 2025, with group revenue remaining flat at HK$1.932 billion; benefiting...
L & M CHEMICAL (00746) released its mid-year performance for 2025, with group revenue remaining stable at HK$1.932 billion; benefiting from significant decrease in energy costs and fallback in raw material prices, profit increased by 36.0% to HK$327 million; gross profit margin increased by 7.4 percentage points to 36.3%, with a proposed interim dividend of 19.5 HK cents per share.
In the chemical business, despite the ongoing uncertainty in geopolitical situations affecting the domestic manufacturing atmosphere and cautious market sentiment, the group's chemical product prices showed individual development compared to the same period last year.
Benefitting from significant decrease in energy costs and fallback in raw material prices, gross profit achieved growth. In the property business, there are still 11 unsold residential units in "Xinyue River". During the period, rental income from the project was approximately HK$1.7 million.
After increasing the dividend payout ratio to 49.6% last year, the group's financial condition remains stable, with a mid-term net debt ratio of 3.2%.
Related Articles

TAI HING GROUP (06811) announces profit growth, with the mid-term shareholders' net profit estimated to increase by about 40 to 45 million Hong Kong dollars compared to the previous year.

HK Stock Market Move | BOAN BIOTECH(06955) rose by over 3%. The Boaoyouping Dexralose peptide injection has been approved for listing in China. Commercialization will be conducted in partnership with Shangyi Holdings.

HK Stock Market Move | HARMONY AUTO(03836) rose by over 26% again, BYD Company Limited's overseas momentum is strong, the company is the overseas distributor for BYD Company Limited.
TAI HING GROUP (06811) announces profit growth, with the mid-term shareholders' net profit estimated to increase by about 40 to 45 million Hong Kong dollars compared to the previous year.

HK Stock Market Move | BOAN BIOTECH(06955) rose by over 3%. The Boaoyouping Dexralose peptide injection has been approved for listing in China. Commercialization will be conducted in partnership with Shangyi Holdings.

HK Stock Market Move | HARMONY AUTO(03836) rose by over 26% again, BYD Company Limited's overseas momentum is strong, the company is the overseas distributor for BYD Company Limited.

RECOMMEND

Seven Ministries Issue Comprehensive Roadmap for Brain-Computer Interface Industry Advances
08/08/2025

GPT-5 Makes a Late-Night Debut as Microsoft Leads Integration; Institutions Optimistic About Accelerated AI Programming Development
08/08/2025

Federal Reserve: U.S. Consumer Inflation Expectations Rose in July, Labor Market Sentiment Improved
08/08/2025